Zai Lab ZLAB
NASDAQ ZLAB
$26.25 -0.75 (-2.78%)
As of: Sep 4, 2026 · 2:27 PM EDT

Zai Lab (ZLAB) Equity Income (2018 - 2022)

Analysis

Zai Lab (ZLAB) Equity Income (2018 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - 4.08 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -
10 Zai Lab 2.93 Bn 2.22 Bn 58.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -221,000.00
Dec 31, 2021 -509,000.00
Sep 30, 2021 -340,000.00
Jun 30, 2021 -403,000.00
Mar 31, 2021 195,000.00
Dec 31, 2020 -448,000.00
Sep 30, 2020 -265,000.00
Jun 30, 2020 -269,000.00
Mar 31, 2020 -137,000.00
Dec 31, 2019 -250,246.00
Sep 30, 2019 -185,754.00
Dec 31, 2018 -232,735.00